|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 110.60 EUR | -0.85% |
|
-1.95% | -20.94% |
| 07-18 | Merck KGaA Gets Conditional Approval To Market Ezmekly Drug in EU | DJ |
| 07-18 | Merck KGaA Gets EU Conditional Marketing Approval for Plexiform Neurofibroma Therapy | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 116.45 | 126.25 | 138.2 |
| Spread/Res. | -5.02% | -12.40% | -19.97% |
| Spread/Supp. | +1.51% | +1.51% | +0.27% |
| Support | 108.95 | 108.95 | 110.3 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MRK Stock
- Charts Merck KGaA
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition